Description
CV-65 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity, inhibiting activation of JNK and ERK5 and suppressing proliferation in various tumor cell lines.
CV-65 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity, inhibiting activation of JNK and ERK5 and suppressing proliferation in various tumor cell lines.
| Purity | ≥70% |
|---|---|
| Formula | C14H10N2O4 |
| Formula Wt. | 270.24 |
| Chemical Name | 3,6-Dimethyl-1,8-diazaanthracene-2,7,9,10(1H,8H)-tetrone |
| IUPAC Name | 3,7-dimethyl-1,9-dihydropyrido[3,2-g]quinoline-2,5,8,10-tetrone |
| Appearance | Orange Solid |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
Pipaón C, Gutierrez P, Montero JC, et al. Mitogen-activated protein kinase routes as targets in the action of diaza-anthracene compounds with a potent growth-inhibitory effect on cancer cells. Mol Cancer Ther. 2002 Aug;1(10):811-9. PMID: 12492114.
NSAID; COX-1/2 and PDE inhibitor.
JAK2 inhibitor
EZH2 inhibitor
Diterpene found in Anisomeles.
MEK1/2 and ERK inhibitor.
PI3K inhibitor, microtubule polymerization inhi...
Aminoglycoside; protein translation inhibitor.<...
Naturally sourced ITC, sulfonyl analog of sulfo...
RARα/β agonist.
Steviol glycoside used as sucrose substitute
Abl inhibitor.
Endogenous peptide; actin polymerization inhibi...
ERK1/2 inhibitor.
Pt-based DNA cross-linker.
An omega-3 fatty acid.
L-type and T-type Ca2+ and TRP antagonist.
Cap-dependent endonuclease inhibitor
NSAID; COX-2 inhibitor.
5-HT2 antagonist, SERT and NET inhibitor, hERG ...
FXR agonist.